Posts

Showing posts from April, 2019

Polycab India Ltd IPO - Should You Subcribe?

Image
Incorporated in January 1996, Mumbai based Polycab India Ltd is going to debut in the primary market with its IPO on April 5, 2019. Today, Polycab is a household name. The famous Bollywood actor Paresh Rawal is brand ambassador of the company and appear every now and then on television, advertisement signboards and hoardings.  Issue details : This IPO is a mix of Offer For Sale and Fresh Issue. The company is going to garner Rs. 400  Crore through Fresh Issue and existing shareholders are offloading 1,75,82,000 shares under Offer For Sale arrangement which are 12.45% of pre-offer issued, subscribed and paid up shares. Total issue sizes is for Rs. 1346 Crore approx.  The issue is opening on April 5, 2019 and closing on April 9, 2019. The tentative dates of allotment and listing are April 15, 2019 and April 18,2019 respectively. The price is Rs. 533 - Rs. 538 per share. There is no discount to retail investors but employees are offered discount of Rs. 53 per share. Minimum

Metropolis Healthcare Ltd IPO - Should you subscribe?

Image
Converted from partnership firm into company in July 2003, Metropolis Healthcare Limited is a brand in healthcare sector.  After MSTC Listing failed, Rail Vikas Nigam Ltd has not received good response on the third day of opening, and even by the time this article is being written. Metropolis Healthcare Ltd IPO is  the sixth mainline IPO of the year 2019. This is yet another 100% offer for share. Overview : The company offers a broad range of approximately 3,487 clinical laboratory tests and 530 profiles, as of December 31, 2018. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into (i) ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; (ii) ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and (iii